BrianJMoranMD

Benign Diseases, Urologic Cancer

Medical Director, Chicago Prostate Cancer Center, Westmont, IL Medical Director, DuPage Medical Group Cancer Center, Lisle, IL

Join to view full profile

Dr. Moran is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Moran's full profile

Already have an account?

Office
403 Warrenville Rd.
Ste. 100
Lisle, IL 60532
Phone+1 630-432-6745

Fax+1 630-432-6608
Is this information wrong?

Education & Training

Loyola University Medical CenterResidency, Radiation Oncology, 1988 - 1991
Loyola Medicine MacNeal HospitalInternship, Transitional Year, 1987 - 1988
Loyola University Chicago Stritch School of MedicineClass of 1987
Illinois Benedictine CollegeB.A., Philosophy and Biology

Certifications & Licensure

IL State Medical License 1987 - 2026
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

American Association of Retired Persons 50@50+ Award, 2017
Darrell J. Stremler Leadership Award DuPage Medical Group, 2013
Resident Teaching Award Lutheran General Hospital, 1995, 1997
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Join now to see all

Clinical Trials

Comparison of Between ThinSeed™ and OncoSeed™ for Permanent Prostate Brachytherapy Start of enrollment: 2010 Apr 01
Unknown status
Phase 4

Publications & Presentations

PubMed

3 citations
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.
Sagar A Patel, Ting Martin Ma, Jessica K Wong, Bradley J Stish, Robert T Dess, Avinash Pilar, Chandana Reddy, Trude B Wedde, Wolfgang A Lilleby, Ryan Fiano, Gregory S ...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Mar 1
15 citations
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Pros...
Amar U Kishan, Alison Steigler, James W Denham, Almudena Zapatero, Araceli Guerrero, David Joseph, Xavier Maldonado, Jessica K Wong, Bradley J Stish, Robert T Dess, Av...> ;JAMA Oncology. 2022 Mar 1
12 citations
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk ...
Michael Xiang, Ting Martin Ma, Ricky Savjani, Erqi L Pollom, R Jeffrey Karnes, Tristan Grogan, Jessica K Wong, Giovanni Motterle, Jeffrey J Tosoian, Bruce J Trock, Eri...> ;JAMA Network Open. 2021 Dec 1
The risk of death from prostate cancer in men with Gleason score 3+4 prostate cancer treated using brachytherapy with or without a short course of androgen deprivation...
David D. Yang, Ming-Hui Chen, Jing Wu, Michelle H. Braccioforte, Brian J. Moran, Anthony V. D'Amico> ;Urologic Oncology. 2021 Jul 24
6 citations
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.
Amar U. Kishan, R. Jeffrey Karnes, Tahmineh Romero, J.K. Wong, Giovanni Motterle, Jeffrey J. Tosoian, Bruce J. Trock, Eric A. Klein, Bradley J. Stish, Robert T. Dess, ...> ;JAMA Network Open. 2021 Jul 1
12 citations
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.
R. Philipson, Tahmineh Romero, J.K. Wong, Bradley J. Stish, Robert T. Dess, Daniel E. Spratt, Avinash Pilar, Chandana A. Reddy, Trude B. Wedde, Wolfgang Lilleby, Ryan ...> ;European Urology. 2021 May 10
2 citations
Long-term outcomes of a prospective randomized trial of 131Cs/125I permanent prostate brachytherapy.
Brian J. Moran, Antony Koroulakis, C. DeCesaris, Michelle H. Braccioforte, Neha P. Amin, Manuj Agarwal> ;Brachytherapy. 2021 Jan 1
5 citations
Long-term biochemical outcomes using cesium-131 in prostate brachytherapy
Brian J. Moran, Stephanie R. Rice, Arpit M. Chhabra, Neha P. Amin, Michelle H. Braccioforte, Manuj Agarwal> ;Brachytherapy. 2019 Nov 1
58 citations
Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality.
Derya Tilki, Ming-Hui Chen, Jing Wu, Hartwig Huland, Markus Graefen, Michelle H. Braccioforte, Brian J. Moran, Anthony V. D'Amico> ;JAMA Oncology. 2019 Feb 1
4 citations
Long-term outcomes analysis of low-dose-rate brachytherapy in clinically T3 high-risk prostate cancer.
Manuj Agarwal, Arpit M. Chhabra, Neha P. Amin, Michelle H. Braccioforte, Jason K. Molitoris, Brian J. Moran> ;Brachytherapy. 2018 Nov 1
5 citations
Brachytherapy monotherapy may be sufficient for a subset of patients with unfavorable intermediate risk prostate cancer.
Martin T. King, Ming-Hui Chen, Brian J. Moran, Michelle H. Braccioforte, Ivan Buzurovic, Vinayak Muralidhar, David D. Yang, Kent W. Mouw, Phillip M. Devlin, Anthony V....> ;Urologic Oncology. 2017 Dec 21
14 citations
Race and mortality risk after radiation therapy in men treated with or without androgen‐suppression therapy for favorable‐risk prostate cancer
Konstantin A. Kovtun, Ming-Hui Chen, Michelle H. Braccioforte, Brian J. Moran, Anthony V. D'Amico> ;Cancer. 2016 Dec 1
1 citations
Androgen Deprivation Therapy Use in the Setting of High-dose Radiation Therapy and the Risk of Prostate Cancer-Specific Mortality Stratified by the Extent of Competing...
Brent S Rose, Ming-Hui Chen, Jing Wu, Michelle H Braccioforte, Brian J Moran, Daniel E Doseretz, Michael J Katin, Rudolf H Ross, Sharon A Salenius, Anthony V D'Amico> ;International Journal of Radiation Oncology, Biology, Physics. 2016 Nov 15
3 citations
Influence of Comorbidity on the Risk of Mortality in Men With Unfavorable-Risk Prostate Cancer Undergoing High-Dose Radiation Therapy Alone.
Mai Anh Huynh, Ming-Hui Chen, Jing Wu, Michelle H. Braccioforte, Brian J. Moran, Anthony V. D'Amico> ;International Journal of Radiation Oncology, Biology, Physics. 2016 Jul 15
1 citations
Comorbidity and the Receipt of Curative Therapy for Favorable-risk Prostate Cancer Prior to and Following the Publication of PIVOT
Stephen A. Mihalcik, Ming-Hui Chen, Michelle H. Braccioforte, Brian J. Moran, Anthony V. D'Amico> ;European Urology Focus. 2016 Mar 3
48 citations
Impact of the Cell Cycle Progression Test on Physician and Patient Treatment Selection for Localized Prostate Cancer
Neal D. Shore, Naveen Kella, Brian J. Moran, Judd Boczko, Fernando J. Bianco, E. David Crawford, Thaylon Davis, Kirstin M. Roundy, Kristen Rushton, Charles E. Grier, R...> ;The Journal of Urology. 2016 Mar 1
37 citations
Definition and validation of "favorable high-risk prostate cancer": Implications for personalizing treatment of radiation-managed patients
Vinayak Muralidhar, Ming-Hui Chen, Gally Reznor, Brian J. Moran, Michelle H. Braccioforte, Clair J. Beard, Felix Y. Feng, Karen E. Hoffman, Toni K. Choueiri, Neil E. M...> ;International Journal of Radiation Oncology, Biology, Physics. 2015 Nov 15
1 citations
Short-course androgen deprivation therapy and the risk of death from high-risk prostate cancer in men undergoing external beam radiation therapy and brachytherapy.
Ann C. Raldow, Danjie Zhang, Ming-Hui Chen, Michelle H. Braccioforte, Brian J. Moran, Anthony V. D'Amico> ;Brachytherapy. 2015 Nov 1
47 citations
Gleason Score 3 + 5 or 5 + 3 versus 4 + 4 Prostate Cancer: The Risk of Death
Mai Anh Huynh, Ming-Hui Chen, Jing Wu, Michelle H. Braccioforte, Brian J. Moran, Anthony V. D'Amico> ;European Urology. 2016 Jun 1
63 citations
Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer
David R. Ziehr, Ming-Hui Chen, Danjie Zhang, Michelle H. Braccioforte, Brian J. Moran, Brandon A. Mahal, Andrew S. Hyatt, Shehzad Basaria, Clair J. Beard, Joshua A. Be...> ;BJU International. 2015 Sep 1
61 citations
Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer
Ann C. Raldow, Danjie Zhang, Ming-Hui Chen, Michelle H. Braccioforte, Brian J. Moran, Anthony V. D'Amico> ;JAMA Oncology. 2015 Jun 1
26 citations
Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate-risk disease
Florence K. Keane, Ming-Hui Chen, Danjie Zhang, Brian J. Moran, Michelle H. Braccioforte, Anthony V. D'Amico> ;Cancer. 2015 Aug 15
35 citations
Establishing high-quality prostate brachytherapy using a phantom simulator training program
Nikhil G. Thaker, Rajat J. Kudchadker, David A. Swanson, Jeffrey M. Albert, Usama Mahmood, Thomas J. Pugh, Nicholas S. Boehling, Teresa L. Bruno, Bradley R. Prestidge,...> ;International Journal of Radiation Oncology, Biology, Physics. 2014 Nov 1
19 citations
Neoadjuvant Hormonal Therapy Use and the Risk of Death in Men with Prostate Cancer Treated with Brachytherapy Who Have No or at Least a Single Risk Factor for Coronary...
Akash Nanda, Ming-Hui Chen, Brian J. Moran, Michelle H. Braccioforte, Daniel E. Dosoretz, Sharon Salenius, Michael J. Katin, Rudi Ross, Anthony V. D'Amico> ;European Urology. 2014 Jan 1
9 citations
Cardiovascular Comorbidity and Mortality in Men With Prostate Cancer Treated With Brachytherapy-Based Radiation With or Without Hormonal Therapy
Akash Nanda, Ming-Hui Chen, Brian J. Moran, Michelle H. Braccioforte, Anthony V. D'Amico> ;International Journal of Radiation Oncology, Biology, Physics. 2013 Apr 1
Join now to see all

Press Mentions

A Decade of Data Shows the Value of Isorays Cesium-131 as Prostate Cancer Internal Radiation Therapy TreatmentSeptember 18th, 2019
Life SaverSeptember 1st, 2017

Committees

Chairman, DuPage Medical Group Cancer Committee (Commission on Cancer Accredited Program) 2012 - Present
Member, Medicare CAC Committee for Radiation Oncology 1997 - Present
Board Trustee, Chicago Radiological Society 1996 - 1998
Nomination Committee, Chicago Radiological Society 1994 - 1995
Vice Chairman of Public and Professional Communications Committee, American Society of Therapeutic Radiology Oncology 1994 - 1994
Member, Lutheran General Hospital Radiation Safety Committee 1993 - 1997
Chairman, Alexian Brothers Medical Center Radiation Safety Committee 1993 - 1997
Program Director - Radiation Oncology Section, Chicago Radiological Society 1992 - 1997
Member, Lutheran General Hospital Cancer Committee 1991 - 1997
Member, Alexian Brothers Medical Center Cancer Committee 1991 - 1997
Wellness Community Member, Professional Advisory Committee 1989 - 1994